Journal of Clinical Oncology · 1987 · 60 citations · 18 references
MedicineHematologyOncologyCytogeneticsHematologic OncologyHematopathologyBone Marrow EvaluationBone Marrow PathologyCancer Survival AnalysisClinical HematologyHematologic MalignanciesHematologic PathologyBone Marrow AssessmentChronic LeukemiasHematologic Malignancy DiagnosticsLymph Node Involvement PrognosisLymphoid Neoplasm PrognosisPrognostic VariablesRegional Lymph Node InvolvementUnivariate Analysis
Clinical and biological data were evaluated using Desu univariate analyses or Cox multivariate analyses in a series of 1,777 chronic lymphocytic leukemia (CLL) patients from an Italian Cooperative Group. In univariate analyses, age and sex of patients, presence of bone marrow (BM; greater than or equal to 50%), and peripheral blood (PB; greater than or equal to 60,000/microL) lymphocytosis, anemia (hemoglobin [Hb] less than 11 g/dL), thrombocytopenia (less than 100,000/microL), direct Coombs' test positivity, hepatomegaly, splenomegaly, and extent of lymph node involvement were shown to be of significant prognostic value. Multivariate analyses, through a stepwise procedure, showed that the most important prognostic variables are Hb, hepatomegaly, lymph node involvement, PB lymphocytosis, and age and sex of patients. Further covariates would produce an improvement having a nonsignificant P value. Based on the results of multivariate analyses, a four-step staging using the significant variables of the Cox model is proposed.
18
Clinical staging of chronic lymphocytic leukemia
KR Rai, A Sawitsky, Cronkite Ep et al. · Blood · 1975 · 2.7K citations
Medicine, Hematology, Oncology +13